期刊文献+

103例原发性胆囊癌疗效及预后评析 被引量:9

The therapeutic effect and prognostic study on 103 cases gallbladder carcinomas
暂未订购
导出
摘要 目的总结原发性胆囊癌的临床特征和外科治疗经验,探讨不同的治疗方式对其预后的影响,并对影响其预后的因素进行分析。方法回顾我院2000年6月至2007年6月收治的113例胆囊癌的临床资料,分析肿瘤分期、外科手术方式等相关因素与预后之间的关系。结果 103例患者获随访,患者平均生存时间(19.6±18.4)个月,1、3、5年生存率分别为55.0%、25.0%、8.0%;根治性切除组患者1、3、5年生存率分别为81.0%、42.0%、19.0%,与姑息手术组、剖腹探查组比较差异有统计学意义(P<0.05);其中扩大根治者生存(16.2±3.7)个月,明显长于姑息性切除术者的(9.2±1.1)个月(P<0.05)。Cox多因素分析显示,肿瘤的浸润深度、淋巴结转移、远处转移和治疗方法与胆囊癌的预后独立相关。结论胆囊癌的早期症状不典型,早期发现率低,早期诊断和手术是提高胆囊癌预后的关键。高危患者可适当放宽胆囊切除的指征,对未能手术的高危患者应定期随访、严密监测;对晚期胆囊癌应行积极的、个体化的综合治疗,根治术或扩大根治术是提高患者长期生存率的有效手段。 Objective To evaluate the correlation between pancreatic-phase CT enhancement and histopathological grades,intratumoral microvessel density(MVD) and expressions of vascular endothelial growth factor(VEGF) in pancreatic carcinoma.Methods Thirty patients with pancreatic carcinoma underwent CT scanning before resection.The enhancement degrees and forms of tumor were observed in pancreatic-phase.The operative sample was stained with HE and marked with immunohistochemistry,and the histopathological grades,MVD and expression of VEGF of pancreatic carcinoma were examined.The correlation of CT enhancement of the tumor and the pathological grades,MVD counting in hot spots areas of neoplastic parenchyma cells,expression of VEGF of pancreatic carcinoma were comparatively analyzed.Results CT enhancement of tumor was inversely proportional to the malignant degree of pancreatic carcinoma(r=0.733,t=5.708,P0.001) and the MVD counting in the hot spot areas of tumor(r=0.778,t=6.551,P0.001).The pathological grade positively correlated with MVD(r=0.437,t=7.574,P0.05),and have no correlation with VEGF expression(r=-0.240,t=-1.306,P0.05).Mean MVD in group with positive expression of VEGF was 57.7±11.1,which in group with negative VEGF expression was 44.6±12.2(t=3.018,P0.05).Conclusion The extent of CT en-hancement is highly related to the malignant degree of pancreatic carcinoma and the MVD counting in the hot spot areas of tumor.The malignant degree of pancreatic carcinoma and VEGF expression are highly related to the MVD counting.
出处 《肝胆胰外科杂志》 CAS 2010年第5期398-401,共4页 Journal of Hepatopancreatobiliary Surgery
关键词 原发性胆囊癌 诊断 治疗 根治术 pancreatic neoplasms pathology microvessel density vascular endothelial growth factor tomography X-ray computed
  • 相关文献

参考文献10

  • 1Levy AD,Murakata LA,Rohrmann CA Jr.Gallbladder carcinoma:radiologic pathologic correlation[J].Radiographics,2001,21(2):295-314.
  • 2Reddy SK,Marroquin CE,Kuo PC,et al.Extended hepatic resection for gallbladder cancer[J].Am J Surg,2007,194(3):355-361.
  • 3Kondo S,Nimura Y,Hayakawa N,et al.Extensive surgery for carcinoma of the gallbladder[J].Br J Surg,2002,89(2):179-181.
  • 4Maluends GF,Diaz JJc,Areerahala UX,et al.Stratedies for the surgical treastmemt of gallbladder cancer[J].Rev Med Chil,2005,133(6):723-728.
  • 5石景森.走出胆囊癌诊断的思维误区[J].临床外科杂志,2006,14(2):68-69. 被引量:13
  • 6石景森,孙学军.原发性胆囊癌诊治的历史、现状及展望[J].西安交通大学学报(医学版),2007,28(5):473-477. 被引量:39
  • 7Kondo S,Nimura Y,Havakawa N,et al.Regional and paraaortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma[J].Br J Surg,2000,87(4):418-422.
  • 8Araid T,Yoshikawa T,Azuma T,et al.Indications for pancreatoduodenectomy in patients undergoing lymphadenectomy for advanced gallbladder carcinoma[J].Hepatobiliury Pancreat Surg,2004,11(1):45-49.
  • 9Wakabayashi H,Ishimura K,Hashimoto N,et al.Analysis of prognostic factors after surgery for stage Ⅲ and Ⅳ gallbladder cancer[J].Surg Oncol,2004,30(8):842-846.
  • 10Houry S,Barrier A,Huguier M.Irradiation therapy for gallbladder carcinoma:recent advances[J].Hepatobiliary Pancreat Surg,2001,8(6):518-524.

二级参考文献8

共引文献47

同被引文献60

  • 1欧阳杰,汤地,匡铭,彭宝岗,梁力建.意外胆囊癌的临床病理特点与预后分析[J].中华临床医师杂志(电子版),2011,5(12):3441-3444. 被引量:5
  • 2卢珠明,张华,王铭辉,崔东海,杨艳旗,黄洪铮.胸段食管鳞癌淋巴结转移强度和淋巴结清扫手术方式分析[J].癌症,2006,25(5):604-608. 被引量:38
  • 3唐志宇,吴育连,高顺良,沈宏伟.胆囊癌术后感染性并发症的危险因素分析[J].实用肿瘤杂志,2007,22(1):54-58. 被引量:2
  • 4Biswas PK.Carcinoma gallbladder[J].Mvmensingh Med J,2010,19(3):477-481.
  • 5Abahssain H,Afchain P,Melas N,et al.Chemotherapy in gallbladder carcinoma[J].Presse Med,2010,39(12):1238-1245.
  • 6Neufeld KL.Nuclear APC[J].Adv Exp Med Biol,2009,656:13-29.
  • 7Narvzhnv SN.Proliferating cell nuclear antigen:a proteomics view[J].Cell Mol Life Sci,2008,65(23):3789-3808.
  • 8Kitazumi I,Tsukahara M.Regulation of DNA fragmentation:the role of caspases and phosphorvlation[J].FEBS J,2011,278(3):427-441.
  • 9Portt L,Norman C,Clapp C,et al.Anti-apoptosis and cell survival:a review[J].Biochim Biophys Acta,2011,1813(1):238-259.
  • 10Hoshi T,Sasano H.Kato K,et al.Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis[J].Anticancer Res,1998,18(6A):4347-4353.

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部